Global ELISA Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to ELISA Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global ELISA Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 ELISA Test Development
1.2.3 ELISA Test Validation
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global ELISA Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Disease Diagnosis
1.3.3 Vaccine Effectiveness Evaluation
1.3.4 Drug Development
1.3.5 Allergen Testing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global ELISA Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global ELISA Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global ELISA Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global ELISA Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 ELISA Test Development Market Size by Players
3.3.2 ELISA Test Validation Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global ELISA Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global ELISA Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global ELISA Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America ELISA Testing Service Market Size by Type (2020-2031)
6.4 North America ELISA Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America ELISA Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe ELISA Testing Service Market Size by Type (2020-2031)
7.4 Europe ELISA Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe ELISA Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific ELISA Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific ELISA Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific ELISA Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America ELISA Testing Service Market Size by Type (2020-2031)
9.4 Central and South America ELISA Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America ELISA Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa ELISA Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa ELISA Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa ELISA Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boster Bio
11.1.1 Boster Bio Corporation Information
11.1.2 Boster Bio Business Overview
11.1.3 Boster Bio ELISA Testing Service Product Features and Attributes
11.1.4 Boster Bio ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Boster Bio ELISA Testing Service Revenue by Product in 2024
11.1.6 Boster Bio ELISA Testing Service Revenue by Application in 2024
11.1.7 Boster Bio ELISA Testing Service Revenue by Geographic Area in 2024
11.1.8 Boster Bio ELISA Testing Service SWOT Analysis
11.1.9 Boster Bio Recent Developments
11.2 RayBiotech
11.2.1 RayBiotech Corporation Information
11.2.2 RayBiotech Business Overview
11.2.3 RayBiotech ELISA Testing Service Product Features and Attributes
11.2.4 RayBiotech ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 RayBiotech ELISA Testing Service Revenue by Product in 2024
11.2.6 RayBiotech ELISA Testing Service Revenue by Application in 2024
11.2.7 RayBiotech ELISA Testing Service Revenue by Geographic Area in 2024
11.2.8 RayBiotech ELISA Testing Service SWOT Analysis
11.2.9 RayBiotech Recent Developments
11.3 R&D Systems, Inc
11.3.1 R&D Systems, Inc Corporation Information
11.3.2 R&D Systems, Inc Business Overview
11.3.3 R&D Systems, Inc ELISA Testing Service Product Features and Attributes
11.3.4 R&D Systems, Inc ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 R&D Systems, Inc ELISA Testing Service Revenue by Product in 2024
11.3.6 R&D Systems, Inc ELISA Testing Service Revenue by Application in 2024
11.3.7 R&D Systems, Inc ELISA Testing Service Revenue by Geographic Area in 2024
11.3.8 R&D Systems, Inc ELISA Testing Service SWOT Analysis
11.3.9 R&D Systems, Inc Recent Developments
11.4 ELISA Technologies, Inc.
11.4.1 ELISA Technologies, Inc. Corporation Information
11.4.2 ELISA Technologies, Inc. Business Overview
11.4.3 ELISA Technologies, Inc. ELISA Testing Service Product Features and Attributes
11.4.4 ELISA Technologies, Inc. ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 ELISA Technologies, Inc. ELISA Testing Service Revenue by Product in 2024
11.4.6 ELISA Technologies, Inc. ELISA Testing Service Revenue by Application in 2024
11.4.7 ELISA Technologies, Inc. ELISA Testing Service Revenue by Geographic Area in 2024
11.4.8 ELISA Technologies, Inc. ELISA Testing Service SWOT Analysis
11.4.9 ELISA Technologies, Inc. Recent Developments
11.5 Cellular Technology Limited
11.5.1 Cellular Technology Limited Corporation Information
11.5.2 Cellular Technology Limited Business Overview
11.5.3 Cellular Technology Limited ELISA Testing Service Product Features and Attributes
11.5.4 Cellular Technology Limited ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Cellular Technology Limited ELISA Testing Service Revenue by Product in 2024
11.5.6 Cellular Technology Limited ELISA Testing Service Revenue by Application in 2024
11.5.7 Cellular Technology Limited ELISA Testing Service Revenue by Geographic Area in 2024
11.5.8 Cellular Technology Limited ELISA Testing Service SWOT Analysis
11.5.9 Cellular Technology Limited Recent Developments
11.6 Virology Research Services Ltd
11.6.1 Virology Research Services Ltd Corporation Information
11.6.2 Virology Research Services Ltd Business Overview
11.6.3 Virology Research Services Ltd ELISA Testing Service Product Features and Attributes
11.6.4 Virology Research Services Ltd ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 Virology Research Services Ltd Recent Developments
11.7 Chimera Biotec
11.7.1 Chimera Biotec Corporation Information
11.7.2 Chimera Biotec Business Overview
11.7.3 Chimera Biotec ELISA Testing Service Product Features and Attributes
11.7.4 Chimera Biotec ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Chimera Biotec Recent Developments
11.8 NorthEast BioLab
11.8.1 NorthEast BioLab Corporation Information
11.8.2 NorthEast BioLab Business Overview
11.8.3 NorthEast BioLab ELISA Testing Service Product Features and Attributes
11.8.4 NorthEast BioLab ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 NorthEast BioLab Recent Developments
11.9 Sino Biological, Inc
11.9.1 Sino Biological, Inc Corporation Information
11.9.2 Sino Biological, Inc Business Overview
11.9.3 Sino Biological, Inc ELISA Testing Service Product Features and Attributes
11.9.4 Sino Biological, Inc ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Sino Biological, Inc Recent Developments
11.10 Kaneka Eurogentec S.A.
11.10.1 Kaneka Eurogentec S.A. Corporation Information
11.10.2 Kaneka Eurogentec S.A. Business Overview
11.10.3 Kaneka Eurogentec S.A. ELISA Testing Service Product Features and Attributes
11.10.4 Kaneka Eurogentec S.A. ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Prove Laboratory Services
11.11.1 Prove Laboratory Services Corporation Information
11.11.2 Prove Laboratory Services Business Overview
11.11.3 Prove Laboratory Services ELISA Testing Service Product Features and Attributes
11.11.4 Prove Laboratory Services ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 Prove Laboratory Services Recent Developments
11.12 KCAS Bio
11.12.1 KCAS Bio Corporation Information
11.12.2 KCAS Bio Business Overview
11.12.3 KCAS Bio ELISA Testing Service Product Features and Attributes
11.12.4 KCAS Bio ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 KCAS Bio Recent Developments
11.13 BioCat GmbH
11.13.1 BioCat GmbH Corporation Information
11.13.2 BioCat GmbH Business Overview
11.13.3 BioCat GmbH ELISA Testing Service Product Features and Attributes
11.13.4 BioCat GmbH ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 BioCat GmbH Recent Developments
11.14 Aviva Systems Biology Corporation
11.14.1 Aviva Systems Biology Corporation Corporation Information
11.14.2 Aviva Systems Biology Corporation Business Overview
11.14.3 Aviva Systems Biology Corporation ELISA Testing Service Product Features and Attributes
11.14.4 Aviva Systems Biology Corporation ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.14.5 Aviva Systems Biology Corporation Recent Developments
11.15 Eve Technologies
11.15.1 Eve Technologies Corporation Information
11.15.2 Eve Technologies Business Overview
11.15.3 Eve Technologies ELISA Testing Service Product Features and Attributes
11.15.4 Eve Technologies ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.15.5 Eve Technologies Recent Developments
11.16 Boster Biological Technology
11.16.1 Boster Biological Technology Corporation Information
11.16.2 Boster Biological Technology Business Overview
11.16.3 Boster Biological Technology ELISA Testing Service Product Features and Attributes
11.16.4 Boster Biological Technology ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.16.5 Boster Biological Technology Recent Developments
11.17 Bio-Techne
11.17.1 Bio-Techne Corporation Information
11.17.2 Bio-Techne Business Overview
11.17.3 Bio-Techne ELISA Testing Service Product Features and Attributes
11.17.4 Bio-Techne ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.17.5 Bio-Techne Recent Developments
11.18 Precision Medicine Group, LLC
11.18.1 Precision Medicine Group, LLC Corporation Information
11.18.2 Precision Medicine Group, LLC Business Overview
11.18.3 Precision Medicine Group, LLC ELISA Testing Service Product Features and Attributes
11.18.4 Precision Medicine Group, LLC ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.18.5 Precision Medicine Group, LLC Recent Developments
11.19 ACROBiosystems
11.19.1 ACROBiosystems Corporation Information
11.19.2 ACROBiosystems Business Overview
11.19.3 ACROBiosystems ELISA Testing Service Product Features and Attributes
11.19.4 ACROBiosystems ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.19.5 ACROBiosystems Recent Developments
11.20 mabtech
11.20.1 mabtech Corporation Information
11.20.2 mabtech Business Overview
11.20.3 mabtech ELISA Testing Service Product Features and Attributes
11.20.4 mabtech ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.20.5 mabtech Recent Developments
11.21 Cellular Technology Limited（immunospot）
11.21.1 Cellular Technology Limited（immunospot） Corporation Information
11.21.2 Cellular Technology Limited（immunospot） Business Overview
11.21.3 Cellular Technology Limited（immunospot） ELISA Testing Service Product Features and Attributes
11.21.4 Cellular Technology Limited（immunospot） ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.21.5 Cellular Technology Limited（immunospot） Recent Developments
11.22 Pestka Biomedical Laboratories, Inc
11.22.1 Pestka Biomedical Laboratories, Inc Corporation Information
11.22.2 Pestka Biomedical Laboratories, Inc Business Overview
11.22.3 Pestka Biomedical Laboratories, Inc ELISA Testing Service Product Features and Attributes
11.22.4 Pestka Biomedical Laboratories, Inc ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.22.5 Pestka Biomedical Laboratories, Inc Recent Developments
11.23 ProteoGenix
11.23.1 ProteoGenix Corporation Information
11.23.2 ProteoGenix Business Overview
11.23.3 ProteoGenix ELISA Testing Service Product Features and Attributes
11.23.4 ProteoGenix ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.23.5 ProteoGenix Recent Developments
11.24 Kaneka Eurogentec S.A
11.24.1 Kaneka Eurogentec S.A Corporation Information
11.24.2 Kaneka Eurogentec S.A Business Overview
11.24.3 Kaneka Eurogentec S.A ELISA Testing Service Product Features and Attributes
11.24.4 Kaneka Eurogentec S.A ELISA Testing Service Revenue and Gross Margin (2020-2025)
11.24.5 Kaneka Eurogentec S.A Recent Developments
12 ELISA Testing ServiceIndustry Chain Analysis
12.1 ELISA Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 ELISA Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global ELISA Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global ELISA Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global ELISA Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global ELISA Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global ELISA Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global ELISA Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global ELISA Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global ELISA Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global ELISA Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ELISA Testing Service as of 2024)
Table 11. Global ELISA Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global ELISA Testing Service Companies Headquarters
Table 13. Global ELISA Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global ELISA Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global ELISA Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global ELISA Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global ELISA Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. ELISA Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America ELISA Testing Service Growth Accelerators and Market Barriers
Table 25. North America ELISA Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe ELISA Testing Service Growth Accelerators and Market Barriers
Table 27. Europe ELISA Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific ELISA Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific ELISA Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America ELISA Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America ELISA Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa ELISA Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa ELISA Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Boster Bio Corporation Information
Table 35. Boster Bio Description and Major Businesses
Table 36. Boster Bio Product Features and Attributes
Table 37. Boster Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Boster Bio Revenue Proportion by Product in 2024
Table 39. Boster Bio Revenue Proportion by Application in 2024
Table 40. Boster Bio Revenue Proportion by Geographic Area in 2024
Table 41. Boster Bio ELISA Testing Service SWOT Analysis
Table 42. Boster Bio Recent Developments
Table 43. RayBiotech Corporation Information
Table 44. RayBiotech Description and Major Businesses
Table 45. RayBiotech Product Features and Attributes
Table 46. RayBiotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. RayBiotech Revenue Proportion by Product in 2024
Table 48. RayBiotech Revenue Proportion by Application in 2024
Table 49. RayBiotech Revenue Proportion by Geographic Area in 2024
Table 50. RayBiotech ELISA Testing Service SWOT Analysis
Table 51. RayBiotech Recent Developments
Table 52. R&D Systems, Inc Corporation Information
Table 53. R&D Systems, Inc Description and Major Businesses
Table 54. R&D Systems, Inc Product Features and Attributes
Table 55. R&D Systems, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. R&D Systems, Inc Revenue Proportion by Product in 2024
Table 57. R&D Systems, Inc Revenue Proportion by Application in 2024
Table 58. R&D Systems, Inc Revenue Proportion by Geographic Area in 2024
Table 59. R&D Systems, Inc ELISA Testing Service SWOT Analysis
Table 60. R&D Systems, Inc Recent Developments
Table 61. ELISA Technologies, Inc. Corporation Information
Table 62. ELISA Technologies, Inc. Description and Major Businesses
Table 63. ELISA Technologies, Inc. Product Features and Attributes
Table 64. ELISA Technologies, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. ELISA Technologies, Inc. Revenue Proportion by Product in 2024
Table 66. ELISA Technologies, Inc. Revenue Proportion by Application in 2024
Table 67. ELISA Technologies, Inc. Revenue Proportion by Geographic Area in 2024
Table 68. ELISA Technologies, Inc. ELISA Testing Service SWOT Analysis
Table 69. ELISA Technologies, Inc. Recent Developments
Table 70. Cellular Technology Limited Corporation Information
Table 71. Cellular Technology Limited Description and Major Businesses
Table 72. Cellular Technology Limited Product Features and Attributes
Table 73. Cellular Technology Limited Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Cellular Technology Limited Revenue Proportion by Product in 2024
Table 75. Cellular Technology Limited Revenue Proportion by Application in 2024
Table 76. Cellular Technology Limited Revenue Proportion by Geographic Area in 2024
Table 77. Cellular Technology Limited ELISA Testing Service SWOT Analysis
Table 78. Cellular Technology Limited Recent Developments
Table 79. Virology Research Services Ltd Corporation Information
Table 80. Virology Research Services Ltd Description and Major Businesses
Table 81. Virology Research Services Ltd Product Features and Attributes
Table 82. Virology Research Services Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Virology Research Services Ltd Recent Developments
Table 84. Chimera Biotec Corporation Information
Table 85. Chimera Biotec Description and Major Businesses
Table 86. Chimera Biotec Product Features and Attributes
Table 87. Chimera Biotec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Chimera Biotec Recent Developments
Table 89. NorthEast BioLab Corporation Information
Table 90. NorthEast BioLab Description and Major Businesses
Table 91. NorthEast BioLab Product Features and Attributes
Table 92. NorthEast BioLab Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. NorthEast BioLab Recent Developments
Table 94. Sino Biological, Inc Corporation Information
Table 95. Sino Biological, Inc Description and Major Businesses
Table 96. Sino Biological, Inc Product Features and Attributes
Table 97. Sino Biological, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Sino Biological, Inc Recent Developments
Table 99. Kaneka Eurogentec S.A. Corporation Information
Table 100. Kaneka Eurogentec S.A. Description and Major Businesses
Table 101. Kaneka Eurogentec S.A. Product Features and Attributes
Table 102. Kaneka Eurogentec S.A. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Kaneka Eurogentec S.A. Recent Developments
Table 104. Prove Laboratory Services Corporation Information
Table 105. Prove Laboratory Services Description and Major Businesses
Table 106. Prove Laboratory Services Product Features and Attributes
Table 107. Prove Laboratory Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Prove Laboratory Services Recent Developments
Table 109. KCAS Bio Corporation Information
Table 110. KCAS Bio Description and Major Businesses
Table 111. KCAS Bio Product Features and Attributes
Table 112. KCAS Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. KCAS Bio Recent Developments
Table 114. BioCat GmbH Corporation Information
Table 115. BioCat GmbH Description and Major Businesses
Table 116. BioCat GmbH Product Features and Attributes
Table 117. BioCat GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. BioCat GmbH Recent Developments
Table 119. Aviva Systems Biology Corporation Corporation Information
Table 120. Aviva Systems Biology Corporation Description and Major Businesses
Table 121. Aviva Systems Biology Corporation Product Features and Attributes
Table 122. Aviva Systems Biology Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Aviva Systems Biology Corporation Recent Developments
Table 124. Eve Technologies Corporation Information
Table 125. Eve Technologies Description and Major Businesses
Table 126. Eve Technologies Product Features and Attributes
Table 127. Eve Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Eve Technologies Recent Developments
Table 129. Boster Biological Technology Corporation Information
Table 130. Boster Biological Technology Description and Major Businesses
Table 131. Boster Biological Technology Product Features and Attributes
Table 132. Boster Biological Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Boster Biological Technology Recent Developments
Table 134. Bio-Techne Corporation Information
Table 135. Bio-Techne Description and Major Businesses
Table 136. Bio-Techne Product Features and Attributes
Table 137. Bio-Techne Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Bio-Techne Recent Developments
Table 139. Precision Medicine Group, LLC Corporation Information
Table 140. Precision Medicine Group, LLC Description and Major Businesses
Table 141. Precision Medicine Group, LLC Product Features and Attributes
Table 142. Precision Medicine Group, LLC Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Precision Medicine Group, LLC Recent Developments
Table 144. ACROBiosystems Corporation Information
Table 145. ACROBiosystems Description and Major Businesses
Table 146. ACROBiosystems Product Features and Attributes
Table 147. ACROBiosystems Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. ACROBiosystems Recent Developments
Table 149. mabtech Corporation Information
Table 150. mabtech Description and Major Businesses
Table 151. mabtech Product Features and Attributes
Table 152. mabtech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. mabtech Recent Developments
Table 154. Cellular Technology Limited（immunospot） Corporation Information
Table 155. Cellular Technology Limited（immunospot） Description and Major Businesses
Table 156. Cellular Technology Limited（immunospot） Product Features and Attributes
Table 157. Cellular Technology Limited（immunospot） Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Cellular Technology Limited（immunospot） Recent Developments
Table 159. Pestka Biomedical Laboratories, Inc Corporation Information
Table 160. Pestka Biomedical Laboratories, Inc Description and Major Businesses
Table 161. Pestka Biomedical Laboratories, Inc Product Features and Attributes
Table 162. Pestka Biomedical Laboratories, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Pestka Biomedical Laboratories, Inc Recent Developments
Table 164. ProteoGenix Corporation Information
Table 165. ProteoGenix Description and Major Businesses
Table 166. ProteoGenix Product Features and Attributes
Table 167. ProteoGenix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. ProteoGenix Recent Developments
Table 169. Kaneka Eurogentec S.A Corporation Information
Table 170. Kaneka Eurogentec S.A Description and Major Businesses
Table 171. Kaneka Eurogentec S.A Product Features and Attributes
Table 172. Kaneka Eurogentec S.A Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Kaneka Eurogentec S.A Recent Developments
Table 174. Raw Materials Key Suppliers
Table 175. Distributors List
Table 176. Market Trends and Market Evolution
Table 177. Market Drivers and Opportunities
Table 178. Market Challenges, Risks, and Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources


List of Figures
Figure 1. ELISA Testing Service Product Picture
Figure 2. Global ELISA Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. ELISA Test Development Product Picture
Figure 4. ELISA Test Validation Product Picture
Figure 5. Others Product Picture
Figure 6. Global ELISA Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Disease Diagnosis
Figure 8. Vaccine Effectiveness Evaluation
Figure 9. Drug Development
Figure 10. Allergen Testing
Figure 11. Others
Figure 12. ELISA Testing Service Report Years Considered
Figure 13. Global ELISA Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 15. Global ELISA Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global ELISA Testing Service Revenue Market Share by Region (2020-2031)
Figure 17. Global ELISA Testing Service Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. ELISA Test Development Revenue Market Share by Player in 2024
Figure 20. ELISA Test Validation Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global ELISA Testing Service Revenue Market Share by Type (2020-2031)
Figure 23. Global ELISA Testing Service Revenue Market Share by Application (2020-2031)
Figure 24. North America ELISA Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players ELISA Testing Service Revenue (US$ Million) in 2024
Figure 26. North America ELISA Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America ELISA Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 28. US ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 29. Canada ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 31. Europe ELISA Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players ELISA Testing Service Revenue (US$ Million) in 2024
Figure 33. Europe ELISA Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe ELISA Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. France ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 38. Italy ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 39. Russia ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific ELISA Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players ELISA Testing Service Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific ELISA Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific ELISA Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. Japan ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Australia ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. India ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore ELISA Testing Service Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America ELISA Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players ELISA Testing Service Revenue (US$ Million) in 2024
Figure 56. Central and South America ELISA Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America ELISA Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil ELISA Testing Service Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina ELISA Testing Service Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa ELISA Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players ELISA Testing Service Revenue (US$ Million) in 2024
Figure 62. South America ELISA Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa ELISA Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries ELISA Testing Service Revenue (2020-2025) & (US$ Million)
Figure 65. Israel ELISA Testing Service Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt ELISA Testing Service Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa ELISA Testing Service Revenue (2020-2025) & (US$ Million)
Figure 68. ELISA Testing Service Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit